GlassScriptPhysician profile
Priscilla L Sepe
NPI 1346689940
$3,016.54
in general payments reported to CMS, 2019-2025
32 companies · $377 in 2025
The $377 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,328 · 2020: $700 · 2021: $476 · 2022: $12.69 · 2023: $33.40 · 2024: $90.29 · 2025: $377.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $500.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $382.06 | 2019-2023 | Jardiance |
| Novo Nordisk INC | $369.40 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $250.11 | 2019-2021 | |
| Pfizer INC. | $232.08 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $211.25 | 2019-2025 | Capvaxive, Gardasil 9 |
| Glaxosmithkline, LLC. | $185.74 | 2019-2025 | Shingrix, Arexvy, Fluarix Quadrivalent |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $159.09 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $116.55 | 2019-2020 | |
| Kvk-Tech, INC. | $110.41 | 2019-2022 | |
| Astellas Pharma US INC | $99.42 | 2021-2025 | Veozah |
| Amgen INC. | $78.52 | 2019-2020 | |
| Janssen Biotech, INC. | $69.33 | 2019 | |
| Sanofi-Aventis U.S. LLC | $68.46 | 2019 | |
| Daiichi Sankyo INC. | $63.11 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $61.95 | 2019-2021 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avanir Pharmaceuticals, INC. | $61.14 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $53.52 | 2019-2021 | |
| Exact Sciences Corporation | $52.47 | 2024 | Cologuard Collection Kit |
| Sunovion Pharmaceuticals INC. | $49.45 | 2019 | |
| Lilly USA, LLC | $48.58 | 2019-2020 | |
| Sanofi Pasteur INC. | $40.14 | 2019-2025 | |
| Abbvie INC. | $38.04 | 2019-2021 | |
| Regeneron Healthcare Solutions, INC. | $37.19 | 2019 | |
| Hologic Sales and Service, LLC | $37.15 | 2019-2025 | Aptima |
| Radius Health, INC. | $29.86 | 2019 | |
| Currax Pharmaceuticals LLC | $23.19 | 2019-2020 | |
| Dynavax Technologies Corporation | $20.46 | 2019 | |
| Mylan Pharmaceuticals INC. | $16.60 | 2020 | |
| Arbor Pharmaceuticals, INC. | $13.72 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $13.50 | 2020 | |
| Allergan, INC. | $12.43 | 2019 | |
| Eisai INC. | $11.62 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Priscilla Sepe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.